16
Ascletis
1672.HK·HKEXHangzhou CNFounded 2013500 employees
Small CapbiotechPublicVirology
Platform: Antiviral
Market Cap
$0.3B
All Drugs
2
Clinical Trials
2
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (1672.HK)
Loading 1672.HK stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Fixaderotide | 167-8409 | Phase 2 | 1 | CFTR | Prostate CaWet AMD | ||
| Doxaosocimab | 167-1606 | Phase 1/2 | 1 | CGRP | NMOSDPsoriasis |
SEC Filings & Financial Documents
SEC filings are not available for HKEX-listed companies.
Ascletis trades on HKEX (CN). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (2)